Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies

被引:173
|
作者
Barber, Thomas M. [1 ,2 ]
Hanson, Petra [1 ,2 ]
Weickert, Martin O. [1 ,2 ,3 ]
Franks, Stephen [4 ]
机构
[1] Univ Hosp Coventry & Warwickshire, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England
[2] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[3] Coventry Univ, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England
[4] Imperial Coll London, Inst Reprod Med, London, England
来源
CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH | 2019年 / 13卷
关键词
Polycystic ovary syndrome; obesity; metabolism; OBSTRUCTIVE SLEEP-APNEA; EXERCISE TRAINING-PROGRAM; HORMONE-BINDING GLOBULIN; INSULIN-RESISTANCE; VISCERAL FAT; ANOVULATORY WOMEN; BODY-COMPOSITION; WEIGHT-LOSS; METABOLIC DYSFUNCTION; CARDIOMETABOLIC RISK;
D O I
10.1177/1179558119874042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive. hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition, exacerbated by obesity. There is a close link between obesity and PCOS based on epidemiological data, and more recently corroborated through genetic studies. There are many mechanisms mediating the effects of weight-gain and obesity on the development of PCOS. The metabolic effects of insulin resistance and steroidogenic and reproductive effects of hyperinsulinaemia are important mechanisms. Adipokine production by subcutaneous and visceral fat appears to play a part in metabolic function, However, given the complexity of PCOS pathogenesis, it is important also to consider possible effects of PCOS on further weightgain. or at least on hampering attempts at weight-loss and maintenance through lifestyle changes. Possible mediators of these effects include changes in energy expenditure, mental ill health. or physical inactivity. In this brief review. we discuss the main mechanisms that underlie the association between obesity and PCOS, from divergent perspectives of weight-gain contributing to development of PCOS and vice versa. We also consider novel management options for women with obesity and PCOS.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Obesity and polycystic ovary syndrome
    Barber, Thomas M.
    Franks, Stephen
    CLINICAL ENDOCRINOLOGY, 2021, 95 (04) : 531 - 541
  • [2] Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
    Moran, Lisa J.
    Pasquali, Renato
    Teede, Helena J.
    Hoeger, Kathleen M.
    Norman, Robert J.
    FERTILITY AND STERILITY, 2009, 92 (06) : 1966 - 1982
  • [3] Obesity and Polycystic Ovary Syndrome
    Vrbikova, Jana
    Hainer, Vojtech
    OBESITY FACTS, 2009, 2 (01) : 26 - 35
  • [4] Obesity and polycystic ovary syndrome
    Naderpoor, N.
    Shorakae, S.
    Joham, A.
    Boyle, J.
    De Courten, B.
    Teede, H. J.
    MINERVA ENDOCRINOLOGICA, 2015, 40 (01) : 37 - 51
  • [5] Obesity and Polycystic Ovary Syndrome
    Kim, Jin Ju
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2024, 33 (04) : 289 - 301
  • [6] Management of obesity in adolescents with polycystic ovary syndrome
    Vatopoulou, Anastasia
    Tziomalos, Konstantinos
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (02) : 207 - 211
  • [7] Obesity management in women with polycystic ovary syndrome
    Lim, Siew S.
    Clifton, Peter M.
    Noakes, Manny
    Norman, Robert J.
    WOMENS HEALTH, 2007, 3 (01) : 73 - 86
  • [8] Obesity and lifestyle management in polycystic ovary syndrome
    Hoeger, Kathleen M.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01) : 277 - 294
  • [9] Novel strategies in the management of polycystic ovary syndrome
    Spritzer, P. M.
    Motta, A. B.
    Sir-Petermann, T.
    Diamanti-Kandarakis, E.
    MINERVA ENDOCRINOLOGICA, 2015, 40 (03) : 195 - 212
  • [10] Polycystic ovary syndrome: treatment strategies and management
    Morreale, Hector F. Escobar
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (17) : 2995 - 3008